Xiaoling Feng Selected Research

Xiaoling Feng Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 07/2010
5	Spontaneous Abortion (Miscarriage) 10/2020 - 07/2018
4	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2010
3	Infections 07/2020 - 02/2005
3	Carcinogenesis 01/2020 - 07/2010
2	Insulin Resistance 02/2020 - 01/2020
2	Inflammation (Inflammations) 02/2020 - 01/2020
2	Obesity 02/2020 - 08/2018
2	Neoplasm Metastasis (Metastasis) 07/2018 - 08/2011
1	Triple Negative Breast Neoplasms 01/2022
1	Communicable Diseases (Infectious Diseases) 07/2020
1	COVID-19 07/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2020
1	Hyperandrogenism 02/2020
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Residual Neoplasm 01/2020
1	Hypothermia 08/2018
1	Hypertension (High Blood Pressure) 08/2018
1	Surgical Wound Infection 08/2018
1	Hypoxia (Hypoxemia) 07/2018
1	Adenocarcinoma of Lung 07/2018
1	Habitual Abortion (Recurrent Miscarriage) 07/2018
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Pain (Aches) 09/2016
1	Necrosis 09/2016
1	Gouty Arthritis 09/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2005
1	Wounds and Injuries (Trauma) 06/2004

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 03/2020 - 02/2005
2	Pharmaceutical PreparationsIBA 01/2022 - 07/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2018 - 06/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	perflexane (perfluorohexane)FDA Link 01/2022
1	dipalmitoylphosphatidylserineIBA 01/2022
1	AGRO 100IBA 01/2022
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2020
1	Hormones (Hormone)IBA 07/2020
1	Chloroquine (Aralen)FDA LinkGeneric 07/2020
1	Ritonavir (Norvir)FDA Link 07/2020
1	Metformin (Glucophage)FDA LinkGeneric 07/2020
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 07/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2020
1	N-methyladenosineIBA 03/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2020
1	Bile Acids and Salts (Bile Acids)IBA 02/2020
1	Choline (Choline Chloride)IBA 02/2020
1	Volatile Fatty AcidsIBA 02/2020
1	LipopolysaccharidesIBA 02/2020
1	AndrogensIBA 01/2020
1	ATP dependent 26S protease (26S proteasome)IBA 01/2020
1	BerberineIBA 01/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	bushen huoxueIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	LipidsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2019
1	PTB-Associated Splicing FactorIBA 07/2018
1	Immunologic Factors (Immunomodulators)IBA 07/2018
1	Long Noncoding RNAIBA 07/2018
1	InflammasomesIBA 09/2016
1	shenqiIBA 09/2016
1	Uric Acid (Urate)IBA 09/2016
1	Phosphotransferases (Kinase)IBA 04/2014
1	Metalloproteases (Metalloproteinases)IBA 08/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2011
1	MicroRNAs (MicroRNA)IBA 10/2010
1	3,3'-diindolylmethane (diindolylmethane)IBA 10/2010
1	Estrogens (Estrogen)FDA Link 10/2010
1	Estrogen ReceptorsIBA 10/2010
1	Cyclin-Dependent Kinase 2IBA 07/2010
1	cdc25 PhosphatasesIBA 07/2010
1	indole-3-carbinolIBA 07/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2004

Therapy/Procedure

3	Therapeutics 01/2022 - 07/2010
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Precision Medicine 01/2022
1	Blood Transfusion (Blood Transfusions) 08/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2018
1	Perioperative Period 08/2018
1	Immunotherapy 07/2018